62 units of tirzepatide Compounded GLP-1 - Semaglutide & compounding pharmacies that make tirzepatide

NICE guidance (TA875) recommends that weight loss medications should be part of a comprehensive programme including dietary modification, increased physical activity, and behavioural support within specialist weight management services

Additionally, GLP-1 agonists have shown cardiovascular benefits, including a reduction in the risk of major adverse cardiovascular events, such as heart attack and stroke

A healthcare provider may prescribe the injection for patient-specific needs, but compounded products should only be used under medical supervision

Available at: [accessed March 2026]. vvSELECT Trial: Semaglutide and cardiovascular outcomes in obesity without diabetes

PCOS weight loss treatments: what are your options

This ensures that the clear, effective medication youve inspected is delivered safely